Embryo Viability Assessment System Using Phasor Fluorescence Lifetime Imaging Microscopy
Tech ID: 34856 / UC Case 2018-893-0
Brief Description
A non-invasive imaging system utilizing fluorescence lifetime microscopy and Fourier-transformed phasor analysis to objectively determine embryo viability.
Full Description
- Non-invasive and label-free embryo assessment method
- Quantitative and objective analysis reducing human subjectivity
- Faster evaluation compatible with clinical IVF timeframes
- Minimized photodamage through two-photon excitation
- Deeper imaging with high-resolution fluorescence lifetime data
- Automated calculation of viability index from intrinsic metabolic signals
- Reduces reliance on labor-intensive morphological inspection
Suggested uses
- In vitro fertilization (IVF) clinics for human assisted reproduction
- Animal breeding facilities seeking enhanced embryo selection
- Research institutions studying embryo development and metabolism
- Development of advanced fertility diagnostic and monitoring tools
- Integration into ART workflows to enable single embryo transfer protocols
Advantages
Non-invasive and label-free embryo assessment method
Quantitative and objective analysis reducing human subjectivity
Faster evaluation compatible with clinical IVF timeframes
Minimized photodamage through two-photon excitation
Deeper imaging with high-resolution fluorescence lifetime data
Automated calculation of viability index from intrinsic metabolic signals
Reduces reliance on labor-intensive morphological inspection
Patent Status
| United States Of America |
Issued Patent |
11,869,191 |
01/09/2024 |
2018-893 |
| United States Of America |
Issued Patent |
11,386,559 |
07/12/2022 |
2018-893 |
| |
|